Tamiflu Articles
UK's flu plans "must keep up" with latest evidence
27 November 2006
Stock Commentary - Europe - week to Nov 20, 2006
27 November 2006
Roche responds to Royal Society flu report
27 November 2006
Roche adds neuropsychiatric warnings to Tamiflu's US label
20 November 2006
Japan stock market week to Oct 30, 2006
6 November 2006
American stockpile Tamiflu on flu fears
23 October 2006
Roche reports sales of $23.89B for first three qtrs of 2006, a 4.7% share of global market
23 October 2006
UPDATE: ICAAC 2006 sees strong data on next-gen antibiotics: Tygacil, ceftaroline, cethromycin
9 October 2006
After 2005 crisis, UK flu vaccine delay warning
9 October 2006
Early Tamiflu treatment reduces pneumonia risk
9 October 2006
Roche's Tamiflu reduces death risk from seasonal flu
9 October 2006
Simcere to make and sell cheap Relenza
9 October 2006
Roche fulfils UK's gov's Tamiflu order
2 October 2006
Japan stock market week to July 24, 2006
26 July 2006
China begins licensed Tamiflu production
19 June 2006
Roche in Africa flu vacc deal with Aspen
22 May 2006
Gilead's 1st-qtr sales reach $692.9M, up 61%
15 May 2006
Beximco sees full year 2005 profits of $7.5M
8 May 2006
Japan stock market week to May 1, 2006
8 May 2006
Roche's 1st-qtr 2006 sales rise 22%
8 May 2006
Swissmedic warning on fake Tamiflu
1 May 2006
Japan says asian flu a designated disease
1 May 2006
Roche's Tamiflu stockpile ready for the WHO
24 April 2006
Fake medicine sales on Internet increase
10 April 2006
Roche picks Martek for Tamiflu production
27 March 2006
Amantadine finds new role as Tamiflu adjunct
20 March 2006
WHO outlines global bird flu strategy
20 March 2006
Japan's pharma licks its wounds after NHI cuts
13 March 2006
US HHS buys more antivirals
13 March 2006
Japan recalculates eight drug ingredients due to high sales
27 February 2006
Strong avian flu data on Ampligen/Alferon
27 February 2006
Biolyse Pharma seeks approval for generic Tamiflu
20 February 2006
Japan stock market week to Feb 13, 2006
20 February 2006
GSK to increase Relenza production
6 February 2006
Tamiflu approved for pediatric use in EU
6 February 2006
Japan stock market week to Jan 23
30 January 2006
Lancet: Tamiflu bad choice against seasonal flu
30 January 2006
Amyxa to develop flu drugs from marine micro-orgs and plants
30 January 2006
Amarillo and Bumimedic in IFN license deal
30 January 2006
Roche steps up Tamiflu distribution in US cities
16 January 2006
Stock Commentary - Europe - week to Jan 9
9 January 2006
Roche grants first Indian Tamiflu production license
9 January 2006
Indian firms set to step up Tamiflu production
19 December 2005
Japan stock market week to Nov 28
5 December 2005
Roche reports Tamiflu results at ESWI
19 September 2005
Japan stock market week to August 15
22 August 2005
GSK to benefit from H5N1 flu pandemic contingency plans?
22 August 2005
UK DoH tenders for 2M doses of flu vacc
1 August 2005
Japan stock market week to July 18
25 July 2005
Roche Rx sales grow three times world rate
25 July 2005
Roche files pediatric use of Tamiflu in EU
25 July 2005
Gilead to pull out of Tamiflu deal with Roche
4 July 2005
Japan stock market week to April 25
26 April 2005
Roche 1st-qtr sales, up 17%, beat estimates
25 April 2005
Japan stock market week to April 11
18 April 2005
Japan stock market week to February 21
28 February 2005
Japan stock market week to January 24
31 January 2005
Biota benefits from flu vacc shortage
22 November 2004
Tamiflu effective against H5N1 influenza
15 November 2004
US HHS Sec seeks to assure on flu vaccine
1 November 2004
Chugai blooms under Roche's umbrella
20 September 2004
Warning over UK NICE Tamiflu guidance
6 September 2004
Gilead sees sales jump 30% for 2nd-qtr
9 August 2004
Tokyo pharma stocks - week July 19
26 July 2004
Chugai's 1st 9-mth earnings beat forecasts
8 March 2004
Tokyo pharma stocks - week to Feb 16
23 February 2004
Tokyo pharma stocks - week to Jan 26
2 February 2004
New NICE guidances for England and Wales
6 October 2003
Stock Commentary - Tokyo
2 June 2003
UK NICE issues flu and diabetes guidances
3 March 2003
Roche probed in China over "exploitation"
24 February 2003
Stock commentary - week to Feb 10 - Tokyo
17 February 2003
Flu drug shortage hits Japan, Chugai issues apology
10 February 2003
Roche's Tamiflu launched in UK
3 February 2003
Euro OK for Roche's Tamiflu; launch in 02/03
1 July 2002
BioCryst drops flu drug in Phase III
1 July 2002
Fillip for Roche as three drugs get EU backing
25 March 2002
Tokyo pharma stocks - week to February 18
25 February 2002
Healthy revenue growth at Gilead
11 February 2002
CVT reports positive data for VRI drug
6 December 2001
OSI acquires oncology assets from Gilead in $200 million deal
27 November 2001
Stock Commentary - New York
3 May 2001
J&J ends flu-drug deal with BioCryst
3 May 2001
Despite revenue rise, Gilead loss increases
1 May 2001
Dip in 1st-qtr pharma sales at Roche
11 April 2001
US HMOs reveal their most-accepted drugs
5 April 2001
Net income leaps 50% at Roche in 2000, but pharma sales disappoint
28 February 2001
Roche refiles dossier for Tamiflu in EU
28 February 2001
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
